Jiaju Li

Jiaju Li

Auto-generated profile, based on publicly available information

Jiaju Li

Cardiac Arrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 February 2024 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
JLJiaju Li
Jiaju Li
KCKe Chen
Ke Chen
LHLiu He
Liu He
FLFangyuan Luo
Fangyuan Luo
XWXianqing Wang
Xianqing Wang
JDJianzeng Dong
Jianzeng Dong

29 January 2025 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
JLJiaju Li
Jiaju Li
YLYiwei Lai
Yiwei Lai
CJChao Jiang
Chao Jiang
MLMingxiao Li
Mingxiao Li
ZYZejun Yang
Zejun Yang
JDJianzeng Dong
Jianzeng Dong
Aims: Fibroblast growth factor 23 (FGF23) has been implicated in the occurrence of atrial fibrillation (AF), but its prognostic value in AF patients remains unclear. Methods and results: A total of 35 197 AF patients with available follow-up data (3.56, 0.47–8.92 years) from the UK Biobank were included. Clinical association between serum FGF23 and AF-related outcomes including mortality, heart failure (HF), ischaemic stroke, and dementia were analysed using multivariable Cox regression. In those passed quality control for array sequencing, polygenic score for FGF23 (PGSFGF23) was calculated as genetic instrument, and the association between PGSFGF23 and the occurrence of endpoints after first AF diagnosis were further explored. In 886 patients who diagnosed AF at or prior to the enrolment, elevated serum FGF23 levels were significantly associated with an increased risk of all-cause (37% increase per standard deviation) and cardiovascular (40% increase per standard deviation) mortality and HF (43% increase per standard deviation). A total of 35 197 patients were available for genetic array sequencing data. Using polygenic score including seven independent SNPs reaching genome-wide significance threshold, genetic association analysis indicated that increased PGSFGF23 is associated with reduced risk of HF but increased risk of all-cause mortality and ischaemic stroke. Conclusion: Our findings suggest that FGF23 is a potential biomarker for accessing AF-related outcomes. The paradoxical association between genetic FGF23 and serum FGF23 level highlights the need for further investigation to elucidate the underlying mechanisms.

23 June 2026 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
JLJiaju Li
Jiaju Li
ATAiju Tian
Aiju Tian
KCKeping Chen
Keping Chen
MTMin Tang
Min Tang
QSQi Sun
Qi Sun
YJYuhe Jia
Yuhe Jia